Matches in SemOpenAlex for { <https://semopenalex.org/work/W2551396317> ?p ?o ?g. }
- W2551396317 endingPage "e0166637" @default.
- W2551396317 startingPage "e0166637" @default.
- W2551396317 abstract "Background Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularly among the elderly. Previous studies on the factors associated with mortality in patients hospitalized for CAP revealed a direct association between the type of microorganism involved, the characteristics of the patient and mortality. Vaccination status against pneumococcal disease was not considered. We conducted a retrospective analysis on the mortality rates after a first hospitalization for CAP in north-east Italy with a view to examining especially the role of anti-pneumococcal vaccination as a factor associated with pneumonia-related mortality at one year. Method Between 2012–2013, patients aged 65+ hospitalized with a primary diagnosis of CAP, identified based on International Classification of Diseases, Ninth Revision, Clinical Modification codes 481–486, were enrolled in the study only once. Patients were divided into three groups by pneumococcal vaccination status: 1) 13-valent pneumococcal conjugate vaccine (PCV13) prior to their hospitalization; 2) 23-valent pneumococcal polysaccharide vaccine (PPV23) within 5 years before hospitalization and 3) unvaccinated or PPV23 more than 5 years prior to admission. Gender, age, length of hospital stay and influenza vaccination were considered. Comorbidities were ascertained by means of a properly coded diagnosis. Every patient was followed up for 1 year and the outcome investigated was mortality for any cause and for pneumonia. Results A total of 4,030 patient were included in the study; mean age at the time of admission to hospital was 84.3±7.7; 50.9% were female. 74.2% of subjects had at least one comorbidity; 73.7% has been vaccinated against influenza. Regard to pneumococcal vaccine, 80.4% of patients were not vaccinated, 14.5% vaccinated with PPV23 and 5.1% with PCV13. The 1-year survival rates after hospitalization for pneumonia were 83.6%, 85.9% and 89.3% in the unvaccinated, PPV23 and PCV13 groups, respectively. Regression analysis indicated that the risk of death due to pneumonia increased significantly with age (adjusted OR: 1.073; 1.061–1.085), shorter hospital stay (adjusted OR: 0.981; 0.971–0.990), and male gender (adjusted OR: 1.372; 1.165–1.616). The model also confirmed the pneumococcal 13-valent conjugated vaccine as an independent protective factor for mortality-related pneumonia (adjusted OR: 0.599; 0.390–0.921). Conclusion The main finding of our observational cohort study is a high mortality rate among elderly patients admitted to hospital for pneumonia. The present study suggests a protective role for PCV13 vaccination." @default.
- W2551396317 created "2016-11-30" @default.
- W2551396317 creator A5000015885 @default.
- W2551396317 creator A5062288574 @default.
- W2551396317 creator A5071331288 @default.
- W2551396317 creator A5073933043 @default.
- W2551396317 creator A5075329894 @default.
- W2551396317 creator A5077246918 @default.
- W2551396317 creator A5080067218 @default.
- W2551396317 creator A5083893021 @default.
- W2551396317 date "2016-11-15" @default.
- W2551396317 modified "2023-09-23" @default.
- W2551396317 title "Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience" @default.
- W2551396317 cites W1837481397 @default.
- W2551396317 cites W1866145098 @default.
- W2551396317 cites W1967151018 @default.
- W2551396317 cites W1976023417 @default.
- W2551396317 cites W1997534347 @default.
- W2551396317 cites W2012030177 @default.
- W2551396317 cites W2017697670 @default.
- W2551396317 cites W2034443456 @default.
- W2551396317 cites W2042944880 @default.
- W2551396317 cites W2043762785 @default.
- W2551396317 cites W2053393255 @default.
- W2551396317 cites W2059514973 @default.
- W2551396317 cites W2070792454 @default.
- W2551396317 cites W2087337981 @default.
- W2551396317 cites W2097129414 @default.
- W2551396317 cites W2101806229 @default.
- W2551396317 cites W2102195781 @default.
- W2551396317 cites W2102952170 @default.
- W2551396317 cites W2107281175 @default.
- W2551396317 cites W2129838034 @default.
- W2551396317 cites W2130307906 @default.
- W2551396317 cites W2132164213 @default.
- W2551396317 cites W2135688996 @default.
- W2551396317 cites W2151584633 @default.
- W2551396317 cites W2157780348 @default.
- W2551396317 cites W2180032500 @default.
- W2551396317 cites W2261694286 @default.
- W2551396317 cites W2416900221 @default.
- W2551396317 cites W2467224540 @default.
- W2551396317 cites W2514851038 @default.
- W2551396317 cites W2602921578 @default.
- W2551396317 doi "https://doi.org/10.1371/journal.pone.0166637" @default.
- W2551396317 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5112912" @default.
- W2551396317 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27846277" @default.
- W2551396317 hasPublicationYear "2016" @default.
- W2551396317 type Work @default.
- W2551396317 sameAs 2551396317 @default.
- W2551396317 citedByCount "20" @default.
- W2551396317 countsByYear W25513963172017 @default.
- W2551396317 countsByYear W25513963172018 @default.
- W2551396317 countsByYear W25513963172019 @default.
- W2551396317 countsByYear W25513963172020 @default.
- W2551396317 countsByYear W25513963172021 @default.
- W2551396317 countsByYear W25513963172022 @default.
- W2551396317 crossrefType "journal-article" @default.
- W2551396317 hasAuthorship W2551396317A5000015885 @default.
- W2551396317 hasAuthorship W2551396317A5062288574 @default.
- W2551396317 hasAuthorship W2551396317A5071331288 @default.
- W2551396317 hasAuthorship W2551396317A5073933043 @default.
- W2551396317 hasAuthorship W2551396317A5075329894 @default.
- W2551396317 hasAuthorship W2551396317A5077246918 @default.
- W2551396317 hasAuthorship W2551396317A5080067218 @default.
- W2551396317 hasAuthorship W2551396317A5083893021 @default.
- W2551396317 hasBestOaLocation W25513963171 @default.
- W2551396317 hasConcept C126322002 @default.
- W2551396317 hasConcept C177713679 @default.
- W2551396317 hasConcept C179755657 @default.
- W2551396317 hasConcept C187212893 @default.
- W2551396317 hasConcept C203014093 @default.
- W2551396317 hasConcept C22070199 @default.
- W2551396317 hasConcept C2776102371 @default.
- W2551396317 hasConcept C2777914695 @default.
- W2551396317 hasConcept C2778866548 @default.
- W2551396317 hasConcept C2779301066 @default.
- W2551396317 hasConcept C2779664119 @default.
- W2551396317 hasConcept C2779892413 @default.
- W2551396317 hasConcept C2781253189 @default.
- W2551396317 hasConcept C3020803494 @default.
- W2551396317 hasConcept C523546767 @default.
- W2551396317 hasConcept C54355233 @default.
- W2551396317 hasConcept C71924100 @default.
- W2551396317 hasConcept C86803240 @default.
- W2551396317 hasConceptScore W2551396317C126322002 @default.
- W2551396317 hasConceptScore W2551396317C177713679 @default.
- W2551396317 hasConceptScore W2551396317C179755657 @default.
- W2551396317 hasConceptScore W2551396317C187212893 @default.
- W2551396317 hasConceptScore W2551396317C203014093 @default.
- W2551396317 hasConceptScore W2551396317C22070199 @default.
- W2551396317 hasConceptScore W2551396317C2776102371 @default.
- W2551396317 hasConceptScore W2551396317C2777914695 @default.
- W2551396317 hasConceptScore W2551396317C2778866548 @default.
- W2551396317 hasConceptScore W2551396317C2779301066 @default.
- W2551396317 hasConceptScore W2551396317C2779664119 @default.
- W2551396317 hasConceptScore W2551396317C2779892413 @default.
- W2551396317 hasConceptScore W2551396317C2781253189 @default.